Statements (53)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:accreditation |
AAALAC International
GLP compliant |
| gptkbp:awards |
Excellence in Research
Innovation Award Best Contract Research Organization |
| gptkbp:client |
Academic institutions
Government agencies Biopharmaceutical companies |
| gptkbp:collaborations |
Research institutions
Universities Industry partners |
| gptkbp:employees |
50-100
|
| gptkbp:focus_area |
gptkb:healthcare_organization
gptkb:hospital Neurology Infectious diseases Metabolic disorders |
| gptkbp:founded |
gptkb:2002
|
| gptkbp:founder |
Dr. John Noble
|
| gptkbp:headquarters |
gptkb:Huntingdon_Valley,_Pennsylvania
|
| https://www.w3.org/2000/01/rdf-schema#label |
Noble Life Sciences
|
| gptkbp:industry |
gptkb:Company
|
| gptkbp:key_people |
gptkb:Dr._Jane_Smith
Dr. John Noble |
| gptkbp:location |
gptkb:United_States
|
| gptkbp:mission |
Improving patient outcomes
Advancing drug development |
| gptkbp:partnerships |
Pharmaceutical companies
Biotech firms |
| gptkbp:publishes |
Scientific journals
Conference proceedings White papers |
| gptkbp:research_areas |
Laboratory space
Animal care facilities Clinical trial sites |
| gptkbp:revenue |
Confidential
|
| gptkbp:services |
Clinical research
Preclinical research Regulatory consulting |
| gptkbp:social_responsibility |
gptkb:Community_engagement
gptkb:Sustainability_initiatives Ethical research practices |
| gptkbp:subsidiary |
Noble Bioanalytical Services
Noble Consulting Group |
| gptkbp:technology |
Data management systems
Advanced analytics Laboratory automation |
| gptkbp:vision |
Enhancing scientific knowledge
Leading in preclinical and clinical research |
| gptkbp:website |
www.noblelifesciences.com
|
| gptkbp:bfsParent |
gptkb:Perkin_Elmer_Health_Sciences
|
| gptkbp:bfsLayer |
5
|